Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease

Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes

(2019) Gincy George et al.   GENE

Inflammation and fatigue in early, untreated Parkinson's Disease

(2018) K. Herlofson et al.   ACTA NEUROLOGICA SCANDINAVICA

Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients

(2018) Caroline Perner et al.   Journal of Neuroinflammation

Epidemiology of Parkinson’s disease

(2017) Ole-Bjørn Tysnes et al.   JOURNAL OF NEURAL TRANSMISSION

Serum sPECAM-1 and sVCAM-1 levels are associated with conversion to multiple sclerosis in patients with optic neuritis

(2016) Alicja Kalinowska-Łyszczarz et al.   JOURNAL OF NEUROIMMUNOLOGY

Expression of ICAM1 and VCAM1 Serum Levels in Rheumatoid Arthritis Clinical Activity. Association with Genetic Polymorphisms

(2013) Rosa Elena Navarro-Hernández et al.   DISEASE MARKERS

Mechanisms Underlying Inflammation in Neurodegeneration

(2010) Christopher K. Glass et al.   CELL